The Future of Pharma Consulting

  Marketing in the pharmaceutical industry has always operated under constraints that do not apply to most other sectors. Regulatory compliance requirements shape every asset. Medical, legal, and regulatory review cycles slow every deployment. Promotional standards govern every claim. The result, for most of the last two decades, has been a commercial marketing function that was structurally slower, more risk-averse, and significantly less adaptive than marketing in adjacent industries. Those constraints have not disappeared. What has changed is the emergence of AI-driven capabilities that allow marketing teams to operate with much greater intelligence and agility within those constraints — not around them. The organizations that are figuring this out early are not moving faster by cutting corners. They are moving faster by building better infrastructure for the hard work that compliance and strategy require. The Content Problem That Has Been Hiding in Plain Sight Pharmaceutical ma...